These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8803778)

  • 21. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
    Hollak CE; van Weely S; van Oers MH; Aerts JM
    J Clin Invest; 1994 Mar; 93(3):1288-92. PubMed ID: 8132768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial purification and further characterization of the novel endoglucosaminidase from human serum that hydrolyses 4-methylumbelliferyl-N-acetyl-beta-D-chitotetraoside (MU-TACT hydrolase).
    Overdijk B; Van Steijn GJ; Den Tandt WR
    Int J Biochem; 1994 Dec; 26(12):1369-75. PubMed ID: 7890116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins.
    Renkema GH; Boot RG; Muijsers AO; Donker-Koopman WE; Aerts JM
    J Biol Chem; 1995 Feb; 270(5):2198-202. PubMed ID: 7836450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human serum contains a chitinase: identification of an enzyme, formerly described as 4-methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase (MU-TACT hydrolase).
    Overdijk B; Van Steijn GJ
    Glycobiology; 1994 Dec; 4(6):797-803. PubMed ID: 7734843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages.
    Boot RG; Renkema GH; Strijland A; van Zonneveld AJ; Aerts JM
    J Biol Chem; 1995 Nov; 270(44):26252-6. PubMed ID: 7592832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH-dependent association-dissociation of high and low activity plasma alpha-L-fucosidase.
    Willems PJ; Romeo E; Den Tandt WR; Van Elsen AF; Leroy JG
    Hum Genet; 1981; 59(2):115-8. PubMed ID: 7327570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid phosphatase in Gaucher's disease.
    Robinson DB; Glew RH
    Clin Chem; 1980 Mar; 26(3):371-82. PubMed ID: 6988111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay.
    Brouwer J; van Leeuwen-Herberts T; Otting-van de Ruit M
    Clin Chim Acta; 1984 Sep; 142(1):21-30. PubMed ID: 6383662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid hydrolases in plasma in Gaucher's disease.
    Ockerman PA; Kohlin P
    Clin Chem; 1969 Jan; 15(1):61-4. PubMed ID: 4884797
    [No Abstract]   [Full Text] [Related]  

  • 30. Leroy's l-cell disease: markedly increased activity of plasma acid hydrolases.
    Den Tandt WR; Lassila E; Philippart M
    J Lab Clin Med; 1974 Mar; 83(3):403-8. PubMed ID: 4359899
    [No Abstract]   [Full Text] [Related]  

  • 31. Chitinase in goat serum. Preliminary purification and characterization.
    Lundblad G; Hederstedt B; Lind J; Steby M
    Eur J Biochem; 1974 Jul; 46(2):367-76. PubMed ID: 4211869
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-identity of human plasma lysozyme and 4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase.
    Den Tandt WR; Inaba T; Verhamme I; Overdyk B; Brouwer J; Prieur D
    Int J Biochem; 1988; 20(7):713-9. PubMed ID: 3181601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of hexosaminidase A in homogenates of white blood cells using methylumbelliferyl-N-acetyl-beta-D-glucosaminide-6-sulphate as substrate.
    Den Tandt WR; Scharpe S
    Clin Chim Acta; 1991 Jul; 199(3):231-6. PubMed ID: 1837501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease.
    Silverstein E; Friedland J
    Clin Chim Acta; 1977 Jan; 74(1):21-5. PubMed ID: 188566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of serum angiotensin-converting enzyme in Gaucher's disease.
    Lieberman J; Beutler E
    N Engl J Med; 1976 Jun; 294(26):1442-4. PubMed ID: 179000
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
    Chambers JP; Aquino L; Glew RH; Lee RE; McCafferty LR
    Clin Chim Acta; 1977 Oct; 80(1):67-77. PubMed ID: 20252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients.
    den Tandt WR; van Hoof F
    J Inherit Metab Dis; 1996; 19(3):344-50. PubMed ID: 8803778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
    Suzuki Y
    Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biology of the Gaucher cell: the cradle of human chitinases.
    Bussink AP; van Eijk M; Renkema GH; Aerts JM; Boot RG
    Int Rev Cytol; 2006; 252():71-128. PubMed ID: 16984816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.